Sixth Annual RNAi Roundtable Series - TTRsc02 on Monday next week | ALNY Message Board Posts

Alnylam Pharmaceuticals

  ALNY website


  • Get 3 months of ad-free premium service for every $25 you contribute
    to support critical site improvement efforts.
    With no recurring subscription
    to worry about, this an ideal way to test drive our premium service.

    Premium features, such as multi-message viewing (i.e., being able to open
    up to 100 messages with a single click) can save you lots of time
    over the course of a busy day, to say nothing of an entire year!
    Watch this 2-min video to see why premium is right for you.


    *Offer expires at midnight

ALNY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34684 of 34718  at  9/11/2019 3:26:04 PM  by

evernewbliss


 In response to msg 34683 by  Steve_382
view thread

Re: Sixth Annual RNAi Roundtable Series - TTRsc02 on Monday next week

What do you expect them to say about TTRsc02? P3 study remains blinded so I donít expect anything more than rehashing of the same old information. May be they can give us some update on how enrollment is proceeding. I am more interested in knowing about progress on AAT02 and HBV02.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 84
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34685 Re: Sixth Annual RNAi Roundtable Series - TTRsc02 on Monday next week Steve_382 0 9/12/2019 9:31:47 AM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...